2m 2m 2m 2m 2m 2m 2m
EXAGEN (XGN)
NASDAQ
$8.15+$0.26 (+3.28%)
Price as of Oct 02, 2026 6:26 PM EDT- $191.1MMarket Cap
- -27.55%1-Year Change
- Diagnostics & ResearchIndustry
EXAGEN (XGN)
$8.15+$0.26 (+3.28%)
XGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.89 | ||
Change | -$0.24 (-2.95%) | ||
Open | $8.13 | ||
High | $8.25 | ||
Low | $7.81 | ||
Previous Close | $8.13 | ||
Volume | 401,721 | ||
30-Day Average Volume | 264,897 | ||
1-Week Change | -9.73% | ||
1-Month Change | 10.81% | ||
1-Year Change | -27.55% | ||
3-Year Change | 226.03% | ||
5-Year Change | -43.96% | ||
Fundamentals | |||
Shares Outstanding | 24.2M | ||
Total Assets | $51.9M | ||
Market Cap | $191.1M | ||
Enterprise Value | $189.4M | ||
Period: QTR TTM FY | |||
Revenue | $19.9M | ||
Net Income | -$3.2M | ||
Free Cash Flow | $3.4M | ||
EBIT | -$2.1M | ||
EBITDA | -$1.5M | ||
Net Working Capital | $29.4M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -129 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 16 | ||
P/E | -61 | ||
PEG | -3 | ||
Price/Free Cash Flow | 55 | ||
Price/Operating Cash Flow | 48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue